TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
30.88
-0.06 (-0.19%)
At close: Feb 21, 2025, 4:00 PM
30.58
-0.30 (-0.96%)
After-hours: Feb 21, 2025, 7:52 PM EST
TG Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for TG Therapeutics stock have an average target of 40.67, with a low estimate of 22 and a high estimate of 55. The average target predicts an increase of 31.70% from the current stock price of 30.88.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 15, 2025.
Analyst Ratings
The average analyst rating for TG Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +78.11% | Jan 15, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $30 → $43 | Buy | Maintains | $30 → $43 | +39.25% | Nov 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $49 → $55 | Strong Buy | Maintains | $49 → $55 | +78.11% | Nov 5, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $20 → $22 | Hold | Maintains | $20 → $22 | -28.76% | Nov 5, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +61.92% | Oct 29, 2024 |
Financial Forecast
Revenue This Year
339.34M
from 233.66M
Increased by 45.23%
Revenue Next Year
559.37M
from 339.34M
Increased by 64.84%
EPS This Year
0.08
from 0.09
Decreased by -8.59%
EPS Next Year
0.89
from 0.08
Increased by 991.66%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 427.8M | 663.8M | 888.9M | |||
| Avg | 339.3M | 559.4M | 766.8M | |||
| Low | 308.2M | 462.6M | 630.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 83.1% | 95.6% | 58.9% | |||
| Avg | 45.2% | 64.8% | 37.1% | |||
| Low | 31.9% | 36.3% | 12.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 0.14 | 1.32 | 2.35 | |||
| Avg | 0.08 | 0.89 | 1.83 | |||
| Low | 0.04 | 0.44 | 0.95 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 52.9% | 1,521.3% | 164.0% | |||
| Avg | -8.6% | 991.7% | 105.2% | |||
| Low | -56.1% | 440.4% | 6.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.